Ann Arbor, MI4 Active Studies

Liver Cancer Clinical Trials in Ann Arbor, MI

Find 4 actively recruiting liver cancer clinical trials in Ann Arbor, MI. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
6,000
Enrolling

Recruiting Liver Cancer Studies in Ann Arbor

RecruitingAnn Arbor, MINCT06084234

National Liver Cancer Screening Trial

The National Liver Cancer Screening Trial is an adaptive randomized phase IV Trial comparing ultrasound-based versus biomarker-based screening in 5500 patients with cirrhosis from any etiology or pati...

5,500 participants
University of Texas Southwestern Medical Center
View Study Details
RecruitingAnn Arbor, MINCT05948475

Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

This study is a Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician's Choice in Subjects with Fibroblast Growth Factor...

200 participants
TransThera Sciences (Nanjing), Inc.
View Study Details
RecruitingAnn Arbor, MINCT05440708

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

The primary objectives of Cohort A Phase 1b are to evaluate the safety and tolerability of TTI-101 orally administered as a single agent to participants with locally advanced or metastatic, and unrese...

178 participants
Tvardi Therapeutics, Incorporated
View Study Details
RecruitingAnn Arbor, MINCT05168163

Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

This phase II trial tests whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer...

122 participants
Academic and Community Cancer Research United
View Study Details

About Liver Cancer Clinical Trials in Ann Arbor

Liver cancer most commonly presents as hepatocellular carcinoma (HCC) and is often associated with chronic liver disease or hepatitis. It is one of the fastest-growing causes of cancer death. Treatment options include surgery, liver transplant, ablation, and systemic therapies.

There are currently 4 liver cancer clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 6,000 participants. Research is being sponsored by University of Texas Southwestern Medical Center, TransThera Sciences (Nanjing), Inc., Tvardi Therapeutics, Incorporated and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Liver Cancer Clinical Trials in Ann Arbor — FAQ

Are there liver cancer clinical trials in Ann Arbor?

Yes, there are 4 liver cancer clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Ann Arbor?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.

Are clinical trials in Ann Arbor free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.

What liver cancer treatments are being tested?

The 4 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for liver cancer.

Data updated March 2, 2026 from ClinicalTrials.gov